AviadoBio Funding: $97M Raised, Series A (2021)

AviadoBio funding overview

AviadoBio is based in London, United Kingdom. AviadoBio has raised $97M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2021. The round record for AviadoBio runs through 2021; nothing later has been disclosed. Investors on record include New Enterprise Associates (NEA), Monograph Capital, LSP, Advent Life Sciences, Dementia Discovery Fund (DDF), F-Prime Capital and 2 others. 8 distinct backers are named across the disclosed rounds.

AviadoBio at a glance

Total raised: $97M
Latest round: Series A
Latest round date: December 2021
Headquarters: London, United Kingdom
Notable investors: New Enterprise Associates (NEA), Monograph Capital, LSP, Advent Life Sciences, Dementia Discovery Fund (DDF), F-Prime Capital, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), LifeArc

Frequently asked about AviadoBio funding

How much has AviadoBio raised?: AviadoBio has raised $97M in total disclosed funding across the rounds on record.
Who has invested in AviadoBio?: New Enterprise Associates (NEA), Monograph Capital, LSP, Advent Life Sciences, Dementia Discovery Fund (DDF), F-Prime Capital are named among the investors backing AviadoBio.
What was the latest AviadoBio funding round?: The most recent disclosed round is a Series A, announced in December 2021.
Where is AviadoBio based?: AviadoBio is based in London, United Kingdom.
When did AviadoBio last raise?: The last disclosed AviadoBio round closed in December 2021 at Series A.

AviadoBio totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in London below to benchmark round size and investor mix.

AviadoBio Funding: $97M Raised, Series A (2021)

AviadoBio funding overview

AviadoBio at a glance

Frequently asked about AviadoBio funding

Companies related to AviadoBio (36)

Browse related funding lists (9)